A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 69
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MCMV
Long Form : mouse CMV
No. Year Title Co-occurring Abbreviation
2020 alpha2beta1 Integrin Is Required for Optimal NK Cell Proliferation during Viral Infection but Not for Acquisition of Effector Functions or NK Cell-Mediated Virus Control. ECTV
2020 Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition. CMV, HCMV
2020 Cutting Edge: STAT1-Mediated Epigenetic Control of Rsad2 Promotes Clonal Expansion of Antiviral NK Cells. ---
2020 Cytomegalovirus protein m154 perturbs the adaptor protein-1 compartment mediating broad-spectrum immune evasion. AP-1, CMVs
2020 Prophylactic and Therapeutic HBV Vaccination by an HBs-expressing Cytomegalovirus Vector Lacking an Interferon Antagonist in Mice. CMV, HCMV
2019 A novel murine model of differentiation-mediated cytomegalovirus reactivation from latently infected bone marrow haematopoietic cells. BM, BMCs, DCs, GM-CSF, HCMV, HSCs, IL-4, LPS
2019 Cytomegalovirus Evades TRAIL-Mediated Innate Lymphoid Cell 1 Defenses. CMV, cNK, ILCs, SG, TNF, TRAIL, TRAIL-DR
2019 Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection. CMV, Env, FV, SIV
2019 Life-long control of cytomegalovirus (CMV) by T resident memory cells in the adipose tissue results in inflammation and hyperglycemia. CMV
10  2019 The complex of MCMV proteins and MHC class I evades NK cell control and drives the evolution of virus-specific activating Ly49 receptors. ---
11  2018 FcgammaRI expression on macrophages is required for antibody-mediated tumor protection by cytomegalovirus-based vaccines. CMV
12  2018 IL-27 regulates the number, function and cytotoxic program of antiviral CD4 T cells and promotes cytomegalovirus persistence. CMV
13  2017 Cutting Edge: NKG2D Signaling Enhances NK Cell Responses but Alone Is Insufficient To Drive Expansion during Mouse Cytomegalovirus Infection. ---
14  2017 Enforced OX40 Stimulation Empowers Booster Vaccines to Induce Effective CD4+ and CD8+ T Cell Responses against Mouse Cytomegalovirus Infection. SLPs
15  2017 Immune Protection by a Cytomegalovirus Vaccine Vector Expressing a Single Low-Avidity Epitope. ---
16  2017 Mouse cytomegalovirus encoded immunoevasins and evolution of Ly49 receptors - Sidekicks or enemies? CMVs
17  2017 Recent advances in CMV tropism, latency, and diagnosis during aging. CMV, HCMV
18  2017 The Contribution of Cytomegalovirus Infection to Immune Senescence Is Set by the Infectious Dose. HCMV, LCMV
19  2017 Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein. GAGs
20  2017 UL36 Rescues Apoptosis Inhibition and In vivo Replication of a Chimeric MCMV Lacking the M36 Gene. CMV, HCMV
21  2016 Bile Acids Act as Soluble Host Restriction Factors Limiting Cytomegalovirus Replication in Hepatocytes. CMV, TCDC
22  2016 Conventional Dendritic Cells Confer Protection against Mouse Cytomegalovirus Infection via TLR9 and MyD88 Signaling. cDCs, CMV, DCs, MyD88, NK, pDCs, TLR9
23  2016 Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection. APCs, CMV, CTL, MHC-II
24  2016 Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus. HCMV, RPS14
25  2016 Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection. DNAM, HCMV, PVR
26  2016 Murine cytomegalovirus (CMV) infection via the intranasal route offers a robust model of immunity upon mucosal CMV infection. CMV
27  2016 The Breadth of Synthetic Long Peptide Vaccine-Induced CD8+ T Cell Responses Determines the Efficacy against Mouse Cytomegalovirus Infection. HCMV, SLP
28  2016 Viral Persistence Induces Antibody Inflation without Altering Antibody Avidity. CMV, GC
29  2015 Cutting edge: stage-specific requirement of IL-18 for antiviral NK cell expansion. ---
30  2015 IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection. ---
31  2015 Mck2-dependent infection of alveolar macrophages promotes replication of MCMV in nodular inflammatory foci of the neonatal lung. CMV, MCK2, NIF
32  2015 Type I Interferon Released by Myeloid Dendritic Cells Reversibly Impairs Cytomegalovirus Replication by Inhibiting Immediate Early Gene Expression. CMV, IE, IFN, mDC
33  2014 "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells. SOCS
34  2014 CMV-induced pathology: pathway and gene-gene interaction analysis. CAF, HCMV, MEC, SGs, TME
35  2014 Cutting edge: Salivary gland NK cells develop independently of Nfil3 in steady-state. SG
36  2014 Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection. CMV, IFN, NK
37  2014 Distinct requirements for activation of NKT and NK cells during viral infection. ---
38  2014 Inhibition of the TRAIL death receptor by CMV reveals its importance in NK cell-mediated antiviral defense. CMV, DR, NK, ORF, TRAIL
39  2014 M27 expressed by cytomegalovirus counteracts effective type I interferon induction of myeloid cells but not of plasmacytoid dendritic cells. CMV, RLH, TLR, TLR9
40  2014 Viral MHC class I-like molecule allows evasion of NK cell effector responses in vivo. Deltam157, MHC-I
41  2013 Cytomegalovirus-induced salivary gland pathology: resistance to kinase inhibitors of the upregulated host cell EGFR/ERK pathway is associated with CMV-dependent stromal overexpression of IL-6 and fibronectin. HCMV, MEC, SG, SMGs
42  2013 Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation. DCs
43  2013 Superior induction and maintenance of protective CD8 T cells in mice infected with mouse cytomegalovirus vector expressing RAE-1gamma. CMVs, RAE-1gamma
44  2013 Vascular dysfunction in young, mid-aged and aged mice with latent cytomegalovirus infections. HCMV
45  2012 A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer. CMV, PSA
46  2012 Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging. CMV
47  2012 Eri1 regulates microRNA homeostasis and mouse lymphocyte development and antiviral function. BM, NK
48  2012 Immune senescence: relative contributions of age and cytomegalovirus infection. CMV, LCMV
49  2012 Impact of local endothelial challenge with cytomegalovirus or glycoprotein B on vasodilation in intact pressurized arteries from nonpregnant and pregnant mice. CMV, gB, LP, NP
50  2011 A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus. CMV, EBOV, NP, ZEBOV
51  2011 Dissecting the requirements for maintenance of the CMV-specific memory T-cell pool. CMV
52  2011 Genetic labeling reveals altered turnover and stability of innate lymphocytes in latent mouse cytomegalovirus infection. ---
53  2011 The mouse cytomegalovirus glycoprotein m155 inhibits CD40 expression and restricts CD4 T cell responses. CMV, ORF
54  2010 Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8(+) T cells. ---
55  2010 Can we build it better? Using BAC genetics to engineer more effective cytomegalovirus vaccines. HCMV
56  2010 Differential effects on nitric oxide-mediated vasodilation in mesenteric and uterine arteries from cytomegalovirus-infected mice. CMV, NO, PGHS
57  2010 The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV. HCMV
58  2009 Cytomegalovirus infection causes an increase of arterial blood pressure. ABP, Ang II, CMV, EC, ELISA, HCMV, HHV-8, QRT-PCR
59  2008 Cytomegalovirus induces abnormal chondrogenesis and osteogenesis during embryonic mandibular development. CMV, MANs, NCM
60  2008 Cytomegalovirus inhibition of embryonic mouse tooth development: a model of the human amelogenesis imperfecta phenocopy. CMV
61  2008 Host and donor immune responses contribute to antiviral effects of amotosalen-treated donor lymphocytes following early posttransplant cytomegalovirus infection. ---
62  2008 Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice. CNS, HCMV
63  2006 Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model. CMV
64  2004 Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation. APOE, CMV, p.i
65  2003 Improved detection and quantification of mouse cytomegalovirus by real-time PCR. CMV
66  1999 Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. ---
67  1985 Studies of ocular murine cytomegalovirus infection. CMV, MEF, p.i, SG-MCMV
68  1980 Adverse effects of cytomegalovirus vaccination in mice. CMV
69  1979 Age-related neurocytotropism of mouse cytomegalovirus in explanted trigeminal ganglions. CMV, METC